This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Blue Lotus
Nymphaea caerulea | Egyptian sacred water lily | Aporphine alkaloid botanical (nuciferine + trace apomorphine)
Aliases (9)
Overview
What is Blue Lotus?
Blue Lotus (Nymphaea caerulea) is an aquatic flowering plant of the Nile basin that was a sacred and ceremonial plant in ancient Egypt — depicted in tomb paintings, temple reliefs, and Tutankhamun's burial chamber. Modern community use centers on tea, alcoholic infusion, or vape extract for mild psychoactive effects. Two aporphine alkaloids carry the pharmacology: nuciferine (the dominant alkaloid, present in all market products at variable concentration) and apomorphine (trace amounts only — the same molecule that's an Rx Parkinson's drug, but at exposures orders of magnitude lower than therapeutic Rx doses). The published evidence base is thin: ~5 substantive papers plus a small case-series and historical-pharmacology literature; no clinical efficacy RCTs exist. Legal in the US except Louisiana (banned 2005 under State Act 159 for human consumption); prohibited for US Armed Forces members; banned in Latvia, Poland, Russia (all 2009).
Key Benefits
Mild relaxation, mild mood lift, mild sedative-anxiolytic effect, dream enhancement when used near bedtime, mild aphrodisiac feel (anecdotal). Effect tier is consistently described as gentle rather than dramatic — closer to a soft herbal accent than a potent psychoactive. Onset 15-30 min, duration 1-2 hours, resolution within 3-4 hours. No documented physical dependence at typical use frequencies; no significant next-day carryover at tea doses.
Mechanism of Action
Two pharmacologically distinct aporphine alkaloids in different ratios depending on preparation. Nuciferine (the workhorse) is a partial agonist at dopamine D2 (EC50 = 64 nM, Emax = 67% — aripiprazole-like), D4, D5, and 5-HT6 receptors; antagonist at 5-HT2A/2B/2C; inverse agonist at 5-HT7; agonist at 5-HT1A; plus dopamine-transporter inhibition (Farrell 2016). Functionally aripiprazole-flavored — produces antipsychotic-like and sedative effects in rodent models without catalepsy. Apomorphine is present in trace amounts (often non-detectable in industrial extracts per Dosoky 2023) — at full Rx doses (2-6 mg subQ) it's a non-selective D1/D2 agonist for Parkinson's and ED, but tea-cup exposures are sub-microgram and pharmacologically marginal. The felt effect is overwhelmingly nuciferine, not apomorphine.
Pharmacokinetics
Research Indications
1. Nuciferine — the workhorse alkaloid
Receptor profile (Farrell et al. 2016, PMID 26963248 — the most rigorous in vitro / in vivo characterization paper): - Dopamine D2 partia…
2. Apomorphine — present in trace amounts, mythologized in marketing
Pure-drug pharmacology (where it exists at therapeutic doses): - Non-selective D1 + D2 dopamine agonist — full agonist at both receptor f…
Effect timeline (modern self-report + 1998 historical clinical observation)
- Onset: 15–30 min (oral tea; faster for vape due to pulmonary absorption) - Peak: 30–60 min - Duration: 1–2 hours; resolution within 3–4…
Peptide Interactions
The mild psychoactive niche doesn't synergize cleanly with standard biohacker stack components. Theoretical synergy with magnesium glycinate or apigenin (add…
additive sedation + additive tachycardia in case-reported users; the Hathor-festival historical preparation is a *cultural* context, not a *safety* model
additive GABAergic / depressant load with no evidence of complementary mechanism
theoretical risk of unpredictable D2 partial-agonist + competing dopaminergic interaction; underground literature has nothing safe to say here
additive psychoactivity, additive tachycardia, no synergy benefit for the user's archetype
no documented interaction; if co-occurring in V4-style daily stack, blue lotus is unlikely to negatively interact, but co-use is also redundant (these solve …
Quality Indicators
Correct Species ID (Nymphaea caerulea)
Verify the label says Nymphaea caerulea (or Nymphaea nouchali var. caerulea), not Nelumbo nucifera (sacred / pink lotus — different genus, lower nuciferine content).
Whole Dried Flowers, Visible Blue-Violet Hue
Authentic product is whole dried flowers with visible blue-purple petal coloration. Powdered or crumbled product loses identifiability and is more often adulterated.
COA / Batch Alkaloid Quantification
Rare in this market, but vendors who publish a Certificate of Analysis with quantified nuciferine and apomorphine content are dramatically more reliable than unverified bulk imports.
Strong Floral Smell, No Mold
Product should have a distinct floral smell. Musty / moldy / off odors indicate poor storage or contamination — discard.
Dose-Per-Cup Variability
Even authentic products show wide alkaloid-content variation (Poklis 2017 documented 4-5 orders of magnitude across commercial samples). Without a COA, expect inconsistent effects.
Vape Resin / E-Liquid / Cartridge
Vape preparations linked to the entire published ED case-series literature (Schiff 2021). DoD prohibits for service members. Avoid this product format regardless of vendor.
Mislabeled as Nelumbo nucifera or Generic 'Lotus'
Generic 'lotus' or 'sacred lotus' (Nelumbo nucifera) is a different plant with lower nuciferine and effectively no apomorphine — psychoactive profile is much weaker. Common substitution in cheap product.
Industrial Perfume-Grade Concrete / Absolute
Hexane/ethanol-extracted absolutes (used for fragrance) are nearly free of aporphine alkaloids per Dosoky 2023 — non-psychoactive despite the species ID. Sold as 'blue lotus essential oil' — does not deliver the alkaloid effect users expect.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety
Common (>10% in heavy users / vape route):
- Mild tachycardia (HR rise 10–30 bpm in case-series patients)
- Drowsiness / sedation
- Mild dizziness on standing
- Dry mouth
- Mild GI upset on tea preparations (high tannin content of flower)
Less common (vape route + higher doses):
- Pronounced tachycardia (HR 120–140+ in case-series)
- Altered mental status / disorientation
- Paranoia
- Anxiety surge (paradoxical, in dopamine-sensitive users)
- Chest pain (case-reported, vape route)
Rare-serious (case-reported, mostly vape route):
- Seizure (rare; OPSS DoD guidance flags this)
- "Bizarre behavior" / agitation requiring physical restraint
- Acute psychosis-like presentations in psychiatrically vulnerable users
- Hypoxia (1 case in Schiff 2021, en route via EMS)
Specific watch periods:
- First 30–90 min after dose: primary effect window + tachycardia risk peak
- 3–4 hr post-dose: clinical effects should have resolved; persistent symptoms warrant evaluation
- Co-use with alcohol or other CNS depressants: unsafe — additive sedation + tachycardia
- Vape route: elevated risk regardless of dose intent; avoid
Hard-block contraindications:
- Pregnancy / breastfeeding — no safety data; aporphine alkaloids cross placenta; default conservative
- Seizure history — case reports of blue-lotus-associated seizure; do not use
- Psychosis history / schizophrenia spectrum — D2-active alkaloids in unsupervised dosing are unsafe
- WADA-tested elite athletes — apomorphine on monitoring program; aporphine signature on LC-MS panel could trigger inquiry
- US military service members — DoD prohibition (OPSS guidance); do not use
- Louisiana residence with intent to consume — illegal under State Act 159 (2005)
References
Farrell et al. 2016 — In Vitro and In Vivo Characterization of the Alkaloid Nuciferine (PMID 26963248, PLoS One)
central nuciferine receptor-pharmacology paper
View StudyBertol et al. 2004 — Nymphaea Cults in Ancient Egypt and the New World: A Lesson in Empirical Pharmacology (PMID 14749409, J R Soc Med)
historical-pharmacology argument; PMC mirror PMC1079300
View StudyDosoky et al. 2023 — Chemical Composition, Market Survey, and Safety Assessment of Blue Lotus (Nymphaea caerulea) Extracts (PMID 37894493, Molecules)
industrial-extract composition + safety paper
View StudyPoklis et al. 2017 — The Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the Re-Buildable Dripping Atomizer (PMID 28266899, J Psychoactive Drugs)
vape-resin alkaloid quantification
View StudySchiff et al. 2021 — Toxicity From Blue Lotus After Ingestion or Inhalation: A Case Series (PMID 34345890, Mil Med)
central case-series paper on ED presentations
View StudyEmboden 1989 — The Sacred Journey in Dynastic Egypt: Shamanistic Trance in the Context of the Narcotic Water Lily and the Mandrake (PMID 2656953)
ethnobotanical companion to Bertol 2004
View StudyNuciferine — Wikipedia
receptor binding profile aggregation, structure, plant sources
View StudyNymphaea nouchali var. caerulea — Wikipedia
botanical + historical + regulatory overview
View StudyOPSS (DoD): Blue lotus prohibited for use
official DoD guidance for service members
View StudyLouisiana State Act 159 (2005) — Wikipedia summary
state-level prohibition context
View StudyLouisiana Revised Statutes § 40:989.1 — Justia mirror
primary statutory text
View StudyApomorphine pharmacokinetics in parkinsonian patients (PMID 8370571)
Rx-form PK reference
View StudyApomorphine for Parkinson's disease: pharmacologic and clinical considerations (PMID 37909462)
modern Rx review
View StudyErowid Psychoactive Lily / Lotus Vault — Legal Status
community-aggregated legal status by jurisdiction
View StudyPsychonautWiki: Blue Lotus
community-aggregated subjective effects + harm-reduction framing
View StudyLatest research
- lab-surveyChemical Composition, Market Survey, and Safety Assessment of Blue Lotus (Nymphaea caerulea) ExtractsIndustrial-grade Nymphaea caerulea concrete and absolute extracts contained apomorphine below detection and only ppb-level nuciferine (10–72 ng/g); 27% of identified compounds had no toxicology data. Argues industrial perfume-grade products are essentially non-psychoactive — psychoactivity reports tied to flower/tea/resin formats, not absolute oils.
- case-seriesToxicity From Blue Lotus (Nymphaea caerulea) After Ingestion or Inhalation — A Case SeriesFive active-duty US military patients presenting to ED with altered mental status, tachycardia (HR 121–139), chest pain, paranoia, and "thrashing"; four cases vape-route, one infused beverage. Basis for DoD prohibition; the central paper establishing vape preparations as the high-risk format.
- forensic-toxicologyThe Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the Re-Buildable Dripping AtomizerLC-MS analysis of 5 commercial vape resins quantified nuciferine 10 ppb to 4,300 ng/g (4–5 orders of magnitude variability); apomorphine detected in 2 of 5 samples, absent in 3. Established the product-roulette alkaloid-content problem and the technical viability of nuciferine aerosolization via RDA hardware.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.